Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
CSPC Pharmaceutical Group Ltd., or CSPC, is one of the largest drug manufacturers in China. The company has a diversified portfolio that includes innovative drugs, common generic drugs, and bulk drugs. Its R&D pipeline is primarily focused on cardio-cerebrovascular diseases, digestion and metabolic diseases, oncology, neurology, and anti-infectives.
Shijiazhuang, 050035, Hong Kong